Streetbeat News

Stock Prices

ASST

AVXL

BDRX

PGY

RDHL

RILY

U.S. stocks traded mixed with the Dow down 0.13%, NASDAQ up 0.11%, and S&P 500 down 0.08%. Real estate shares rose by 0.5%, while energy shares fell by 1.1%. U.S. new home sales declined by 5.6%. RedHill Biopharma's shares spiked 214% due to FDA market exclusivity for Talicia. Biodexa Pharmaceuticals surged 131% after acquiring a license for tolimidone. Asset Entities gained 80% after announcing a stock repurchase program. Pagaya Technologies fell 5.5% as CFO stepped down. B. Riley Financial dropped 9% despite Friday's gains. Anavex Life Sciences fell 8% after Q4 results. Oil was down 0.5%, gold up 0.5%, and silver up 1.4%. European and Asian markets closed lower.

Portfolio Pulse from Lisa Levin

November 27, 2023 | 7:30 pm

ASML

ASML Holding (NYSE:ASML) has seen a decrease in short interest, with the short percent of float falling 6.52% since the last report. The company has 1.72 million shares sold short, representing 0.43% of available shares, with a cover time of 1.4 days. This decline in short interest may indicate a more bullish sentiment among investors, although it does not necessarily predict a near-term price rise. ASML's short interest is below its peer group average of 6.73%.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 7:15 pm

SCCO

Southern Copper (NYSE:SCCO) has seen a 15.14% increase in short interest since its last report, with 5.56 million shares sold short, representing 6.54% of its float. The short interest is higher than the peer group average of 3.63%. While an increase in short interest can indicate bearish sentiment, it can also be a bullish sign as explained in a Benzinga Money post.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 7:15 pm

PFE

Pfizer (NYSE:PFE) has seen a 13.4% decrease in short interest since its last report, with 47.18 million shares sold short, representing 0.84% of available shares. The short interest decline suggests a more bullish sentiment among traders, as it would take 1.34 days to cover short positions based on current trading volume. Pfizer's short interest is below its peer group average of 3.22%, indicating less bearish sentiment compared to its peers.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 7:15 pm

XENE

Xenon Pharmaceuticals Inc (NASDAQ:XENE) reported Phase 2 X-NOVA trial results for XEN1101 in patients with MDD, showing positive efficacy signals despite missing the primary endpoint. William Blair remains optimistic about XEN1101's potential in MDD and other CNS disorders, maintaining an Outperform rating with a peak sales potential over $1 billion. XENE shares rose 14.27% to $33.10.

Portfolio Pulse from Vandana Singh

November 27, 2023 | 7:10 pm

NFLX

Netflix Inc (NASDAQ:NFLX) has shown a strong recovery after a 28% drop between July and October 2023, with the stock now up 61% this year and 16% this month. The stock found support at $360 and is facing resistance at $478, a crucial level that was the lowest point in May 2021. If it surpasses this, the next psychological resistance is at $500, followed by the 2022 high of $609. NFLX closed at $479.56 on November 24.

Portfolio Pulse from Zaheer Anwari

November 27, 2023 | 7:02 pm

INTU

Analysts have updated their ratings for Intuit (NASDAQ:INTU) in the last quarter, with 3 bullish, 6 somewhat bullish, and 2 indifferent ratings. The average price target is now $595.82, representing an upside from the current price of $564.07. This target has increased by 9.15% from the previous target of $545.89. Analysts' ratings are based on financial predictions and company performance assessments.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 7:00 pm

LCID

Analysts have provided mixed ratings for Lucid Group (NASDAQ:LCID) with 1 bullish, 5 indifferent, and 1 somewhat bearish rating in the last quarter. The average price target is $5.57, representing a potential upside from the current price of $4.19. This target is a 30.37% decrease from the previous target of $8.00. Analyst ratings are based on information from company events, financial statements, and insider conversations.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 7:00 pm

DCGO

DocGo (NASDAQ:DCGO) has received 7 analyst ratings in the last quarter, with 5 being bullish and 2 somewhat bullish. There have been no indifferent, somewhat bearish, or bearish ratings. The average price target is $13.0, which is significantly higher than the current price of $5.75, suggesting a substantial upside. However, this target is a 13.33% decrease from the previous target of $15.00. Analysts use various methods to rate stocks, and their ratings can influence market perceptions and stock performance.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 7:00 pm

ATOMUSD

Cosmos Hub's cryptocurrency, ATOM, has seen a 5.41% decrease in price over the last 24 hours, settling at $9.13. The downtrend extends over the past week with a 1.0% loss. Despite the price drop, trading volume has increased by 46.0%, and the circulating supply has risen by 0.68%, reaching 292.59 million. ATOM's market cap is currently ranked #29, valued at $2.68 billion.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 7:00 pm